PuSH - Publication Server of Helmholtz Zentrum München

Matsushita, M.* ; Awazawa, M.* ; Kobayashi, N.* ; Ikushima, Y.M.* ; Soeda, K.* ; Tamura-Nakano, M.* ; Muratani, M.* ; Kobayashi, K.* ; Blüher, M. ; Brüning, J.C.* ; Ueki, K.*

An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance.

Cell Chem. Bio. 29, 680-689.e6 (2022)
Publ. Version/Full Text DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
During insulin resistance, lipid uptake by the liver is promoted by peroxisome proliferator-activated protein (PPAR) γ upregulation, leading to hepatic steatosis. Insulin, however, does not directly regulate adipogenic gene expression in liver, and the mechanisms for its upregulation in obesity remain unclear. Here, we show that the Irs2 locus, a critical regulator of insulin actions, encodes an antisense transcript, ASIrs2, whose expression increases in obesity or after refeeding in liver, reciprocal to that of Irs2. ASIrs2 regulates hepatic Pparg expression, and its suppression ameliorates steatosis in obese mice. The human ortholog AL162497.1, whose expression is correlated with that of hepatic PPARG and the severity of non-alcoholic steatohepatitis (NASH), shows genomic organization similar to that of ASIrs2. We also identified HARS2 as a potential binding protein for ASIrs2, functioning as a regulator of Pparg. Collectively, our data reveal a functional duality of the Irs2 gene locus, where reciprocal changes of Irs2 and ASIrs2 in obesity cause insulin resistance and steatosis.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
9.039
1.698
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Pparg ; Fatty Liver ; Insulin Resistance ; Natural Antisense Transcript ; Non-coding Rna
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 2451-9448
e-ISSN 2451-9456
Quellenangaben Volume: 29, Issue: 4, Pages: 680-689.e6 Article Number: , Supplement: ,
Publisher Cell Press
Publishing Place Cambridge, Massachusetts
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-506501-001
G-506500-001
Scopus ID 85128428171
PubMed ID 34986326
Erfassungsdatum 2022-05-31